A Realist Evaluation of Autism ServiCe Delivery (RE-ASCeD)

UnknownOBSERVATIONAL
Enrollment

520

Participants

Timeline

Start Date

November 30, 2019

Primary Completion Date

June 30, 2022

Study Completion Date

December 30, 2022

Conditions
AutismChildrenFamilyDiagnoses, Syndromes, and ConditionsPatient Satisfaction
Interventions
OTHER

Realist evaluation

In-depth exploration of individual service models will be carried out to determine the interrelationship of context, intervention, mechanisms and outcomes as they occur in their natural setting. Data will be gathered within case studies using mixed methods at two levels: (i) service model and (ii) individual child/ family. Methods will include semi structured realist Interviews, focus groups, and document reviews to assemble a comprehensive description of the service and model. Interviewees will include commissioners, service managers, clinicians, referrers, parents and young people. Interviews will be recorded and transcribed, proceeding to qualitative analysis based on components of the programme theory. Regular team meetings will discuss coding, address inconsistencies, and refine collective understanding of coding framework. Coded data will be collated using NVivo software.

Trial Locations (1)

RH16 4BN

RECRUITING

Nightingale Primary Care Centre, Haywards Heath

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Kent

OTHER

collaborator

University of Surrey

OTHER

collaborator

Newcastle University

OTHER

collaborator

Council for Disabled Children

UNKNOWN

collaborator

Autistica

UNKNOWN

collaborator

West Sussex Parent Carer Forum

UNKNOWN

collaborator

Northumberland, Tyne and Wear NHS Foundation Trust

OTHER

collaborator

Cambridgeshire and Peterborough NHS Foundation Trust

OTHER

collaborator

Brighton & Sussex Medical School

OTHER

collaborator

National Health Service, United Kingdom

OTHER_GOV

lead

Sussex Community NHS Foundation Trust

OTHER

NCT04422483 - A Realist Evaluation of Autism ServiCe Delivery (RE-ASCeD) | Biotech Hunter | Biotech Hunter